KZIA — Kazia Therapeutics Share News
0.000.00%
Last trade - 00:00- $0.07m
- -$38.66m
- AU$0.11m
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics
Kazia drops on $40 mln equity offering to fund breast cancer drug
Kazia slides after breast cancer drug update, equity offering launch
Brief: Kazia Therapeutics Limited Announces Proposed Public Offering
Brief: Kazia Therapeutics Reports 100% Clinical Benefit Rate In Initial Six Patients Treated For Advanced Triple-Negative Breast Cancer
Brief: Kazia Therapeutics Announces The Filing Of Provisional Patent For Novel Strategy, Supported By Preclinical Data, To Prevent Metastatic Recurrence In Triple-Negative Breast Cancer
Brief: Kazia Therapeutics Expands Ongoing Phase 1B Trial Of Paxalisib In Advanced Breast Cancer
Buys Global Rights To Setdb1 Platform With $1.39 Million Upfront Payment
Brief: Kazia Therapeutics Ltd Files For Offering Of Up To $200 Million Of American Depositary Shares Representing Ordinary Shares Or Warrants - SEC Filing
NASDAQ RESUMED AT 04:00 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:45 PM
Brief: Kazia Therapeutics Regains Full Nasdaq Listing Compliance
NASDAQ RESUMED AT 09:43 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:38 AM
Brief: Kazia Therapeutics Announces Pricing Of $50.0 Million Private Placement Of Equity Securities
U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet
Microcap Kazia shares soar 40% after positive drug update on single-patient treatment
Brief: Kazia Therapeutics To Request FDA Type C Meeting To Discuss Overall Survival Data In GBM And Potential NDA Filing In Alignment With FDA Initiative Project Frontrunner
Brief: Kazia Therapeutics Announces Collaboration And In-Licensing Agreement For First-In-Class PD-L1 Protein Degrader Program